Ginkgo Bioworks

About:

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

Website: http://ginkgobioworks.com

Twitter/X: ginkgo

Top Investors: General Atlantic, Y Combinator, National Science Foundation, Bill & Melinda Gates Foundation, Illumina

Description:

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Total Funding Amount:

$1.58B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)ginkgobioworks.com

Hub Tags:

Exited Unicorn

Founders:

Austin Che, Barry Canton, Jason Kelly, Reshma Shetty, Tom Knight

Number of Employees:

1001-5000

Last Funding Date:

2024-04-10

IPO Status:

Public

© 2025 bioDAO.ai